| DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) - BioAssay Summary DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target Sequence: RecName: Full=Histamine H1 receptor; Short=H1R; Short=HH1R Description .. ![]() Comment .. ![]() Gene:HRH1 Conserved Domain Related Protein 3D Structures BioActive Compounds: 49 Description: DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) Comment Compounds with activity <= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation. Publication: Journal: NULL Year: NULL Volume: NULL Issue: NULL First Page: NULL Last Page: NULL Categorized Comment ChEMBL Assay Type: Binding ChEMBL Assay Data Source: DrugMatrix in vitro pharmacology assays ChEMBL Assay Test Type: In vitro ChEMBL Assay Cell Type: CHO-K1 ChEMBL Assay Subcellular Fraction: membranes ChEMBL Target ID: 127 ChEMBL target type: Target is a single protein chain Result Definitions
* Activity Concentration. Data Table (Concise) Classification
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||